PT Soho Global Health Tbk (SOHO.JK)
IDR 635.0
(0.0%)
IDR 635.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 8197.75 Billion IDR | 12.45% |
| 2022 | 7290.12 Billion IDR | 3.02% |
| 2021 | 7076.16 Billion IDR | 14.8% |
| 2020 | 6163.93 Billion IDR | 22.1% |
| 2019 | 5048.3 Billion IDR | 10.63% |
| 2018 | 4563.18 Billion IDR | 12.74% |
| 2017 | 4047.67 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2437.3 Billion IDR | -0.27% |
| 2024 Q1 | 2443.81 Billion IDR | 12.66% |
| 2024 Q3 | 2589.57 Billion IDR | 6.25% |
| 2023 Q2 | 1901.77 Billion IDR | -7.56% |
| 2023 FY | 8197.75 Billion IDR | 12.45% |
| 2023 Q4 | 2169.23 Billion IDR | 4.82% |
| 2023 Q3 | 2069.48 Billion IDR | 8.82% |
| 2023 Q1 | 2057.25 Billion IDR | 9.14% |
| 2022 Q4 | 1884.96 Billion IDR | -1.02% |
| 2022 Q3 | 1904.44 Billion IDR | 14.61% |
| 2022 Q2 | 1661.73 Billion IDR | -9.64% |
| 2022 Q1 | 1838.98 Billion IDR | 23.54% |
| 2022 FY | 7290.12 Billion IDR | 3.02% |
| 2021 Q2 | 1792.72 Billion IDR | 10.22% |
| 2021 Q3 | 2168.34 Billion IDR | 20.95% |
| 2021 Q1 | 1626.56 Billion IDR | -3.68% |
| 2021 FY | 7076.16 Billion IDR | 14.8% |
| 2021 Q4 | 1488.53 Billion IDR | -31.35% |
| 2020 Q2 | 1361.01 Billion IDR | -19.62% |
| 2020 Q4 | 1688.69 Billion IDR | 18.84% |
| 2020 Q3 | 1421 Billion IDR | 4.41% |
| 2020 Q1 | 1693.21 Billion IDR | 27.3% |
| 2020 FY | 6163.93 Billion IDR | 22.1% |
| 2019 Q4 | 1330.05 Billion IDR | 0.0% |
| 2019 Q1 | 1203.45 Billion IDR | 0.0% |
| 2019 FY | 5048.3 Billion IDR | 10.63% |
| 2018 FY | 4563.18 Billion IDR | 12.74% |
| 2017 FY | 4047.67 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 28507.87 Billion IDR | 71.244% |
| PT Itama Ranoraya Tbk | 696.3 Billion IDR | -1077.324% |
| PT Kimia Farma (Persero) Tbk | 9965.03 Billion IDR | 17.735% |
| PT Millennium Pharmacon International Tbk | 3363.51 Billion IDR | -143.726% |